• Aloclair Spray is indicated to relieve the pain caused by aphthous mouth ulcers and other minor oral lesions
• Aloclair Spray provides fast pain relief from chafing and irritation caused by braces and ill fitting dentures

• Oral lesions are very common and there are many low-cost branded products available in the market to treat this condition.  However, there is no clear brand leader, which reflects the fact that the market is not served by any highly effective user-friendly products.

  Patients with aphthous ulcers require a product that gives rapid pain relief, accelerates healing, protects against further irritation (e.g. due to spicy food) and is also user-friendly.  Aloclair is formulated and presented as the first product to offer all these benefits.

Aloclair Spray is protected by patents granted in the USA (US6828308) and Europe (EP1313489), Chile, China, New Zealand and South Africa.

Patents are pending in Argentina, Australia, Brazil, Canada, Croatia, Czech Rep., Hong Kong, Hungary, Indonesia, India, Jordan, Japan, South Korea, Mexico, Malaysia, Norway, Pakistan, Philippines, Poland, Russia, Thailand, Taiwan, Ukranian Rep, Venezuela and South Africa.

In the European Union, under the provisions of EEC Directive 93/42/EC Aloclair Spray is considered a Class 1 Medical Device.  

In the U.S.A., Aloclair Spray is registered as a 510(k) OTC medical device.

Marketing companies are required to sell Aloclair in key territories around the world.